Clinical Trials Development Medicine Recombinant Antibody 
XTalks
DECEMBER 12, 2023
Plasma medicine is a critical and specialized field within healthcare, centering on the use of human plasma for the development and administration of life-saving treatments. When people think about innovation drivers in global healthcare, they often think of “big pharma,” and not necessarily companies in the plasma medicines space.
The Pharma Data
JANUARY 18, 2021
By selectively targeting the tumor microenvironment, BT-001 is expected to elicit a much stronger and more effective antitumoral response and greatly increase the safety and tolerability profile of the anti-CTLA4 antibody. BT-001 is being co-developed through a 50/50 collaboration between Transgene and BioInvent. platform).
Expert insights. Personalized for you.
111 
Let's personalize your content